As U.S.-China biotech race heats up, Seattle makes its case to D.C.

From left, Marc Cummings, Life Science Washington; Snehal Patel, Sana Biotechnology; Joe Horsman, Madrona Venture Group; Rebecca Bryant, Fred Hutch Cancer Center; and Alex Zanghellini, Arzeda, at a Seattle forum hosted by the National Security Commission on Emerging Biotechnology on Tuesday. (GeekWire Photo / Sydney Jackson) Arzeda designs enzymes for products ranging from laundry detergent to stevia. But when it comes time to manufacture at commercial scale, the Seattle-based startup often has